Ranked by trial-backed complete cure rates for toenail fungus: oral terbinafine ~40–60%; oral itraconazole ~30–40%; prescription topicals (efinaconazole, tavaborole) 15–20% over 48 weeks; ciclopirox lacquer under 10%; lasers below pills despite the price tag; tea tree oil one small dated trial; Vicks and vinegar essentially untested; and the heavily-advertised "nail renewal" oils and anti-fungal supplements — the funnels this category is famous for — have no clinical trials at all, cannot penetrate the nail plate (oils) or reach the nail bed meaningfully (pills of herbs), and rely on before-after photos across the months in which debridement and regrowth change nails anyway. Test a clipping, use what works, and grow it out.
The cure-rate rankings
The nail fungus guide covers the disease; this page ranks the marketplace. "Complete cure" means clear nail plus negative testing in randomized trials — the only currency that counts in a condition where debridement and regrowth improve photos on their own:
| Treatment | Complete cure (toenails) | Notes |
|---|---|---|
| Oral terbinafine (12 wks, Rx) | ~40–60% | Generic, cheap; the benchmark. Mycological cure higher; FAQ liver context on the condition page. |
| Oral itraconazole (Rx) | ~30–40% | Interaction-prone; second line. |
| Efinaconazole / tavaborole solutions (48 wks, Rx) | ~15–20% | Best-in-class topicals; early/mild disease lane. |
| Ciclopirox / amorolfine lacquers | ~5–12% | Modest; adjunct or mild-case tier. |
| Laser devices | Below oral drugs | FDA-cleared for temporary cosmetic improvement; costly polish. |
| Tea tree oil | Unproven | One small 1990s trial ≈ a weak cream; NCCIH: insufficient evidence. |
| Vicks, vinegar/listerine soaks, oregano oil | Unproven | Anecdote and tiny uncontrolled reports. |
| "Nail renewal" oil/serum funnels | No trials | Cannot penetrate plate; evidence kit dissected in the FAQ. |
| Anti-fungal supplements (pills of herbs, "candida cleanses") | No trials | No demonstrated route to nail-bed drug levels; category adulteration history included. |
Two structural truths explain the table. Penetration is destiny — the plate defeats topicals (FAQ), so efficacy concentrates in systemic drugs. And the market inverts the evidence — advertising spend flows to the untestable tier because the effective tier is generic; nobody buys Super Bowl ads for a $10 pill course, which is precisely why hearing lots about a product predicts little about it working.
Reading this category's marketing
The funnel red-flag list — undated before-afters, ingredient citations posing as product evidence, unnamed "doctors," within-weeks promises against 12-month biology, "fungus is really an internal problem" reframes selling pills of herbs — appears here in its purest form anywhere on this site, and our nail supplement product research applies it to the named products, verification dates attached.
The honest playbook
- Confirm it's fungus — a clipping test; half of look-alikes aren't, and psoriasis or melanoma treated with oils is the category's quiet harm.
- Choose from the top of the table with a prescriber — terbinafine for most confirmed cases seeking clearance; prescription topicals for the mild/early/pill-averse lane; debridement plus shoe-and-skin hygiene regardless.
- Home-tier only with eyes open — the FAQ's narrow early-disease protocol, photographed and time-boxed.
- Diabetes reroutes everything — podiatry, not products.
- Measure the only way nails allow — clear band at the base, monthly photos, verdicts in months. Any product judged faster was judged on hope, which is the ingredient this aisle actually sells.
Frequently asked questions
Why can't creams and oils clear nail fungus when they clear athlete's foot?
Geography. Athlete's foot lives in accessible skin; nail fungus lives in the bed and underside of a plate that evolved to be waterproof armor. Topicals proven for skin barely penetrate it — which is why even purpose-engineered prescription solutions manage 15–20% and cosmetic oils manage approximately nothing. Any rub-on product claiming high cure rates is claiming to beat pharmaceutical chemistry with fragrance.
How do the "nail renewal serum" and fungus-supplement funnels make their evidence look real?
A recognizable kit: dramatic before-afters (undated, or spanning the year in which any debrided nail regrows), "doctor formulated" without a named prescriber, borrowed citations about ingredients-in-a-dish rather than product trials, urgency timers, and claims to "attack fungus from within" — a mechanism oral antifungals achieve only at drug concentrations after absorption pathways herbs don't share. The tell that ends analysis: no product-level trial, ever, for any of them.
Is there any legitimate home-tier option worth trying?
For very early, single-nail, edge-only involvement in someone avoiding prescriptions: a proper OTC antifungal regimen has a defensible-if-modest case — amorolfine lacquer where available OTC, plus religious debridement/filing, athlete's-foot cream for surrounding skin, and the shoe program. Give it 6 months of photographed base growth; progress continues, stall means the prescription conversation. Tea tree oil can join as a low-cost adjunct with expectations set by its single small trial.
What should someone with diabetes do differently?
Skip the experiment tier entirely. Thick fungal nails in diabetic feet are a medical issue — infection portals next to skin that may not report damage — so the route is podiatry/GP: testing, professional debridement, and properly chosen therapy. The months an oil funnel burns are months a diabetic foot shouldn't donate.
References
- MedlinePlus. Fungal nail infection (2023). https://medlineplus.gov/ency/article/001330.htm
- NCCIH. Tea Tree Oil (2020). https://www.nccih.nih.gov/health/tea-tree-oil
- U.S. Food and Drug Administration. Dietary Supplements (2024). https://www.fda.gov/food/dietary-supplements
This page discusses supplement ingredients or categories. It may mention a commercial product, with disclosure. It is general health information, not personal medical advice. Read our editorial policy and medical review policy.